Expertise in
3
conditions

Dr. Samuel N. Lederman

Womens Care Florida LLC
Tampa, FL
Expertise in
3
conditions
Specialties:Obstetrics and Gynecology
Accepting New Patients
Offers Telehealth
Expertise in
3
conditions
OverviewInsuranceLocationsClinical Research

Overview

Samuel Lederman is an Obstetrics and Gynecologist in Tampa, Florida. MD. Lederman is highly rated in 3 conditions, according to our data. His top areas of expertise are Vaginal Yeast Infection, Vulvovaginitis, Thrush, and Neonatal Ovarian Cyst. MD. Lederman is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in FL
Hospital Affiliations
Jupiter Medical Center
Languages Spoken
English
French
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Health Options
  •  UnitedHealthcare
  •  Oscar
  •  Humana
  •  Florida Blue

Locations

WOMENS CARE FLORIDA LLC
2818 W Virginia Ave, Tampa, FL 33607
813-872-8551
Other Locations
WOMENS CARE FLORIDA LLC
4270 Design Ctr Dr, Suite B, Palm Beach Gardens, FL 33410
561-434-0111
WOMENS CARE FLORIDA LLC
4671 S Congress Ave, Suite 100b, Palm Springs, FL 33461
561-434-0111
WOMENS CARE FLORIDA LLC
1500 N Dixie Hwy, Suite 104a, West Palm Beach, FL 33401
561-434-0111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Biological, Device
Study Drug: VGX-3100
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Drug
Study Drug: VT-1161
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
Enrollment Status: Completed
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Enrollment Status: Completed
Publish Date: November 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

6 Total Publications

A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk.
A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk.
Journal: Journal of comparative effectiveness research
Published: May 22, 2023
Similar Doctors
Expertise in
17
conditions
Dr. Robert M. Wenham
Gynecologic Oncology | Obstetrics and Gynecology | Oncology
Expertise in
17
conditions
Dr. Robert M. Wenham
Gynecologic Oncology | Obstetrics and Gynecology | Oncology

H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc

12902 Usf Magnolia Dr, 
Tampa, FL 
 (7.2 mi)
888-860-2778
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Wenham is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Tampa, Florida. Dr. Wenham is highly rated in 17 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Salpingo-Oophorectomy, and Oophorectomy. Dr. Wenham is currently accepting new patients.

Expertise in
10
conditions
Dr. Matthew L. Anderson
Obstetrics and Gynecology | Gynecologic Oncology
Expertise in
10
conditions
Dr. Matthew L. Anderson
Obstetrics and Gynecology | Gynecologic Oncology

Tampa General Medical Group Inc

2 Tampa General Cir, Fl 3, 
Tampa, FL 
 (3.5 mi)
813-844-7585
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Anderson is an Obstetrics and Gynecologist and a Gynecologic Oncologist in Tampa, Florida. Dr. Anderson is highly rated in 10 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Anderson is currently accepting new patients.

Expertise in
18
conditions
Dr. Hye S. Chon
Gynecologic Oncology | Obstetrics and Gynecology
Expertise in
18
conditions
Dr. Hye S. Chon
Gynecologic Oncology | Obstetrics and Gynecology

H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc

12902 Usf Magnolia Dr, 
Tampa, FL 
 (7.2 mi)
888-860-2778
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hye Chon is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Tampa, Florida. Dr. Chon is highly rated in 18 conditions, according to our data. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Gastrostomy, and Hysterectomy. Dr. Chon is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile